Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

In an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...

Isomorphic Labs, a drug discovery company spun out of Google ... trials for drugs designed with the help of Artificial Intelligence. If this goes as planned, it will be a significant milestone in ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...

Demis Hassabis, CEO of Google’s AI research arm DeepMind and a Nobel Prize laureate, isn’t too worried about an AI “jobpocalypse.” Instead of fretting over AI replacing jobs, he’s ...

Google's DeepMind research division claims its newest AI agent marks a significant step toward using the technology to tackle big problems in math and science. The system, known as AlphaEvolve, is ...

It’s a product of DeepMind, which is Google’s parent company’s AI research arm. Oh, and there’s Deep Search, which is part of the new AI Mode coming to Google Search.

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...